Now You See It. Now You Don't: Fair Balance and Adequate Provision in Advertisements for Drugs Before and After the Switch From Prescription to Over-the-Counter

Health Communication

Volumn 27, Issue 1, 2012, Pages 66-74

  Faerber, Adrienne E ^a   Kreling, David H ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NON PRESCRIPTION DRUG; PRESCRIPTION DRUG;

ADVERTIZING; ARTICLE; HUMAN; METHODOLOGY; RISK ASSESSMENT; TELEVISION;

ADVERTISING AS TOPIC; HUMANS; NONPRESCRIPTION DRUGS; PRESCRIPTION DRUGS; RISK ASSESSMENT; TELEVISION;

EID: 84857091715     PISSN: 10410236     EISSN: None     Source Type: Journal    
DOI: 10.1080/10410236.2011.569001     Document Type: Article

References (31)

1. Abel, G. A., Lee, S. J. and Weeks, J. C. 2007. Direct-to-consumer advertising in oncology: A content analysis of print media. Journal of Clinical Oncology, 25: 1267-1271. doi:10.1200/JCO.2006.09.5968
2. Althaus, S. L., Edy, J. A. and Phalen, P. F. 2002. Using the Vanderbilt television abstracts to track broadcast news content: Possibilities and pitfalls. Journal of Broadcasting & Electronic Media, 46: 473
3. Bell, R. A., Wilkes, M. S. and Kravitz, R. L. 2000. The educational value of consumer-targeted prescription drug print advertising. Journal of Family Practice, 49: 1092-1098.
4. Brownfield, E. D., Bernhardt, J. M., Phan, J. L., Williams, M. V. and Parker, R. M. 2004. Direct-to-consumer drug advertisements on network television: An exploration of quantity, frequency, and placement. Journal of Health Communication, 9: 491-497. doi:10.1080/10810730490523115
5. Byrd-Bredbenner, C. and Grasso, D. 1999. Prime-time health: An analysis of health content in television commercials broadcast during programs viewed heavily by children. International Electronic Journal of Health Education, 2: 159-169.
6. Byrt, T., Bishop, J. and Carlin, J. B. 1993. Bias, prevalence and kappa. Journal of Clinical Epidemiology, 46: 423-429.
7. DeLorme, D. E., Huh, J., Reid, L. N. and An, S. 2010. The state of public research on over-the-counter advertising. International Journal of Pharmaceutical and Healthcare Marketing, 4: 208-231.
8. Division of Drug Marketing, Advertising and Communications, Food and Drug Administration. (1999). Consumer-directed broadcast advertisements. http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM070065. pdf (http://www.fda.gov/downloads/Drugs/ GuidanceComplianceRegulatoryInformation/Guidances/UCM070065. pdf)
9. Division of Drug Marketing, Advertising and Communications, Food and Drug Administration. 2009. Presenting risk information in prescription drug and medical device promotion
10. Farris, P. W. and Albion, M. S. 1980. The impact of advertising on the price of consumer products. Journal of Marketing, 44: 17-35.
11. Frosch, D. L., Grande, D., Tarn, D. M. and Kravitz, R. L. 2010. A decade of controversy: Balancing policy with evidence in the regulation of prescription drug advertising. American Journal of Public Health, 100: 24-32. doi:10.2105/AJPH.2008.153767
12. Greene, J. A. and Herzberg, D. 2010. Hidden in plain sight: Marketing prescription drugs to consumers in the twentieth century. American Journal of Public Health, 100: 793-803. doi:10.2105/AJPH.2009.181255
13. Hunt, M. 1998. Direct-to-consumer advertising of prescription drugs, Washington, DC: National Health Policy Forum.
14. Johnsen, D. 2000. Price changes in RX to OTC switches, Unpublished master's thesis, University of Wisconsin-Madison.
15. Juhl, R. P. 1998. Prescription to over-the-counter switch: A regulatory perspective. Clinical Therapeutics, 20: C111-C117.
16. Kaphingst, K. A., DeJong, W., Rudd, R. E. and Daltroy, L. H. 2004. A content analysis of direct-to-consumer television prescription drug advertisements. Journal of Health Communication, 9: 515-528. doi:10.1080/10810730490882586
17. Kim, W. J. and King, K. W. 2009. Product category effects on external search for prescription and nonprescription drugs. Journal of Advertising, 38(1): 5-19.
18. Macias, W. and Lewis, L. S. 2005. How well do direct-to-consumer, DTC, prescription drug web sites meet FDA guidelines and public policy concerns?. Health Marketing Quarterly, 22: 45
19. Macias, W., Pashupati, K. and Lewis, L. S. 2007. A wonderful life or diarrhea and dry mouth? Policy issues of direct-to-consumer drug advertising on television. Health Communication, 22: 241-252. doi:10.1080/10410230701626893
20. Mahecha, L. A. 2006. Outlook-Rx-to-OTC switches: Trends and factors underlying success. Nature Reviews Drug Discovery, 5: 380-385.
21. Main, K. J., Argo, J. J. and Huhmann, B. A. 2004. Pharmaceutical advertising in the USA: Information or influence?. International Journal of Advertising, 23(1): 119
22. Martino, M., & Staton, T. (2008). Big pharma's top 13 advertising budgets. http://www.fiercepharma.com/special-reports/top-13-advertising-budgets (http://www.fiercepharma.com/special-reports/top-13-advertising-budgets)
23. Morris, L. A., Mazis, M. B. and Brinberg, D. 1989. Risk disclosure in televised prescription drug advertising to consumers. Journal of Public Policy and Marketing, 8: 64-80.
24. Nguyen, N. T., Cook, D. M. and Bero, L. A. 2006. The decision-making process of US food and drug administration advisory committees on switches from prescription to over-the-counter status: A comparative case study. Clinical Therapeutics, 28: 1231-1243.
25. Paivio, A. 1991. Dual coding theory-Retrospect and current status. Canadian Journal of Psychology-Revue Canadienne De Psychologie, 45: 255-287.
26. Pember, D. R. and Calvert, C. 2008. Mass media law, Boston: McGraw-Hill Higher Education.
27. Roth, M. S. 1996. Patterns in direct-to-consumer prescription drug print advertising and their public policy implications. Journal of Public Policy & Marketing, 15(1): 63
28. Stephens, E. C. and Johnson, M. M. S. 2000. Dr. mom and other influences on younger and older adults' OTC medication purchases. Journal of Applied Gerontology, 19: 441-459.
29. Sumpradit, N., Ascione, F. J. and Bagozzi, R. P. 2004. A cross-media content analysis of motivational themes in direct-to-consumer prescription drug advertising. Clinical Therapeutics, 26(1): 135-154.
30. The Editors of the New York Times. (2009, August 4, 2009). Should prescription drug ads be reined in? The New York Times. http://roomfordebate.blogs.nytimes.com/2009/08/04/should-prescription -drug-ads-be-reined- (http://roomfordebate.blogs.nytimes.com/2009/08/04/should-prescription -drug-ads-be-reined-)
31. Tsao, J. C. 1997. Informational and symbolic content of over-the-counter drug advertising on television. Journal of Drug Education, 27: 173-197.